Wholesale Bulk Price 3-Iodo-6-Nitro-1-(Oxan-2-Yl)Indazole 2026
- 2026 Market Outlook: Stable pricing anticipated for protected indazole intermediates despite raw material fluctuations.
- Purity Standards: Industrial grade availability exceeds 98% HPLC purity for critical kinase inhibitor synthesis.
- Procurement: Volume discounts apply for 25kg drums with full regulatory documentation (COA, SDS).
The demand for specialized heterocyclic intermediates continues to surge within the pharmaceutical sector, particularly for oncology drug development. Among these, 3-Iodo-6-nitro-1-(oxan-2-yl)indazole stands out as a critical building block. As we approach 2026, procurement strategies must evolve to balance cost efficiency with stringent quality control. This compound, often referred to chemically as 3-Iodo-6-nitro-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, serves as a pivotal precursor in the synthesis of potent kinase inhibitors. Understanding the wholesale bulk price dynamics is essential for supply chain managers and process chemists aiming to secure reliable inventory for large-scale production.
2026 Bulk Market Pricing Trends
The pricing landscape for complex indazole derivatives is influenced by several factors, including the cost of iodine sources, nitration reagents, and the protective group chemistry involved. In the current market, small-scale research quantities often command premium rates due to packaging and handling overheads. However, the bulk price for industrial quantities is projected to stabilize throughout 2026. This stability is driven by optimized production capacities among key suppliers in Asia.
Process chemists must account for the complexity of the synthesis route when evaluating cost proposals. The introduction of the iodine atom at the 3-position and the nitro group at the 6-position requires precise control to avoid regioisomers. Furthermore, the protection of the indazole nitrogen with a tetrahydropyran (THP) group adds a step that ensures stability during subsequent cross-coupling reactions. Suppliers who have streamlined this sequence can offer more competitive rates without compromising on industrial purity. Buyers should expect pricing tiers that reflect the level of purification, with standard grades suitable for early-stage process development and high-purity grades reserved for GMP manufacturing.
Volume Discounts vs Gram-Scale Rates
There is a significant disparity between gram-scale research pricing and multi-kilogram procurement costs. Laboratory suppliers often list prices for 100g or 500g packages that are exponentially higher per unit weight compared to bulk contracts. For example, small pack pricing can exceed hundreds of dollars per kilogram, whereas bulk procurement typically reduces this cost by a factor of ten or more. This economic model rewards long-term planning and accurate demand forecasting.
When transitioning from pilot scale to commercial production, the focus shifts from mere availability to consistency. A global manufacturer with established quality systems can guarantee batch-to-b reproducibility. This is crucial because variations in impurity profiles can affect downstream reaction yields, particularly in palladium-catalyzed coupling steps where the iodine moiety is utilized. Procuring from a source that maintains strict control over residual solvents and heavy metals is non-negotiable for final drug substance approval. Therefore, the initial unit price should be weighed against the technical support and quality assurance provided by the vendor.
Technical Specifications and Quality Control
To ensure the material meets the rigorous demands of pharmaceutical synthesis, buyers must review the Certificate of Analysis (COA) carefully. Key parameters include assay purity, water content, and identification of related substances. The following table outlines the typical specifications expected for high-grade commercial supply:
| Parameter | Specification | Test Method |
|---|---|---|
| CAS Number | 886230-74-6 | N/A |
| Molecular Formula | C12H12IN3O3 | N/A |
| Molecular Weight | 373.15 g/mol | N/A |
| Purity (HPLC) | > 98.0% | Area Normalization |
| Appearance | Off-white to Yellow Solid | Visual |
| Loss on Drying | < 0.5% | Karl Fischer / LOD |
Requesting Custom Quotes for 25kg Drums
For organizations planning commercial campaigns, securing supply in 25kg drums or fiberboard drums is the standard approach. This packaging format minimizes waste and reduces the frequency of ordering cycles. When requesting a custom quote, it is vital to specify the required timeline and destination port to allow the supplier to calculate logistics accurately. Lead times can vary based on raw material availability and production scheduling.
Transparency in production capabilities is another key factor. When evaluating potential partners, inquiries should be made regarding their manufacturing process to ensure alignment with your quality agreements. Suppliers capable of scaling from kilograms to tons without altering the critical quality attributes are preferred. NINGBO INNO PHARMCHEM CO.,LTD. stands as a premier partner in this sector, offering robust supply chains and technical expertise tailored to the needs of international pharmaceutical companies. Their commitment to maintaining high standards ensures that clients receive material that is ready for immediate use in sensitive synthetic pathways.
Documentation and Regulatory Compliance
Beyond the physical product, the accompanying documentation is critical for regulatory filings. A comprehensive dossier should include Safety Data Sheets (SDS), Product Specifications (PS), and Certificates of Origin (COO). The COO is particularly important for customs clearance and determining tariff classifications in different regions. Additionally, traceability through batch numbers allows for quick resolution of any quality queries that may arise during production.
In conclusion, securing the wholesale bulk price for 3-Iodo-6-Nitro-1-(Oxan-2-Yl)Indazole in 2026 requires a strategic approach that values quality and reliability over the lowest initial quote. By partnering with established entities like NINGBO INNO PHARMCHEM CO.,LTD., procurement teams can mitigate supply risks and ensure a steady flow of high-purity intermediates. This stability is fundamental to maintaining production schedules and meeting the critical deadlines associated with new drug applications.